Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-12-17
2010-12-28
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S343500
Reexamination Certificate
active
07858654
ABSTRACT:
Compounds of the formula I:wherein R1is optionally substituted imidazolyl, and R2, R3, R4, R5, R6, R7and R8are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X3and/or a P2X2/3receptor antagonist and methods of making the subject compounds.
REFERENCES:
patent: 6846810 (2005-01-01), Martin et al.
patent: 2001/0000177 (2001-04-01), Dingwei et al.
patent: 2001/0000178 (2001-04-01), Dingwei et al.
patent: 2002/0002193 (2002-01-01), Dingwei et al.
patent: 2003/0187076 (2003-10-01), Agoston et al.
patent: 2004/0171881 (2004-09-01), John et al.
patent: 2005/0009900 (2005-01-01), Dombroski et al.
patent: 2007/0037974 (2007-02-01), Brotherton-Pleiss et al.
patent: 2008/0004442 (2008-01-01), Dillon et al.
patent: 2008/0132494 (2008-06-01), Dillon et al.
patent: 100 55 713 (2002-05-01), None
patent: WO 94/26709 (1994-11-01), None
patent: WO 01/02379 (2001-01-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/92282 (2001-12-01), None
patent: WO 01/92282 (2001-12-01), None
patent: WO 02/00647 (2002-01-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 03/105770 (2003-12-01), None
patent: WO 03/105770 (2003-12-01), None
patent: WO 2004/002999 (2004-01-01), None
patent: WO 2004/002999 (2004-01-01), None
patent: WO 2004/009816 (2004-01-01), None
patent: WO 2004/046331 (2004-06-01), None
patent: WO 2004/046331 (2004-06-01), None
patent: WO 2004/084890 (2004-10-01), None
patent: 2004099146 (2004-11-01), None
patent: WO 2004/094395 (2004-11-01), None
patent: WO 2004/094395 (2004-11-01), None
patent: WO 2005/009418 (2005-02-01), None
patent: WO 2005/009418 (2005-02-01), None
patent: WO 2005/020885 (2005-03-01), None
patent: WO 2005/020885 (2005-03-01), None
patent: 2007020194 (2007-02-01), None
patent: 2008000645 (2008-01-01), None
patent: 2009058298 (2009-05-01), None
Chen Li
Dillon Michael Patrick
Feng Lichun
Hawley Ronald Charles
Yang Minmin
Hall Robert C.
Roche Palo Alto LLC
Willis Douglas M
Wilson James O
LandOfFree
Imidazole-substituted arylamides as P2X 3 and P2X 2/3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole-substituted arylamides as P2X 3 and P2X 2/3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole-substituted arylamides as P2X 3 and P2X 2/3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4172702